drugset

drugset / Trial / NCT07033455

A Trial of HRS-1893 in Healthy Volunteers

NCT07033455 ↗

Phase 0 Completed 20 enrolled Atridia Pty Ltd.

Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and PK characteristics of a single oral dose of HRS-1893 in healthy voluunters.

Timeline

Start: 2025-06-25
Primary completion: 2025-09-05
Completion: 2025-10-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-1893	Unknown	—	Oral

Indications